We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BURL:NYSEBurlington Stores, Inc. Analysis

Data as of 2026-08-19 - not real-time

$336.95

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Burlington Stores, Inc. is bullish at $336.95, with short-term averages leading the long-term ones. Over a rolling month the price has gained 6.6%. With RSI at 38.8 the momentum picture is approaching oversold, alongside a bearish MACD signal. Watch $331.79 as support and $378.33 as the nearer resistance level.
On valuation the read is overvalued — an earnings multiple of 34.6, absent a reliable peer benchmark. Consensus targets land 12.9% above where the shares trade now. Revenue is growing at 14.1% on a 5.2% profit margin.
The composite risk read is 4/10, putting it in moderate territory. With 30-day volatility of 31.9%, a beta of 0.02 and a maximum drawdown of 19.6%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Near-term and long-term part ways here — buy short-term against hold longer out, with 2/10 conviction on the long call.

Top Market Events

BURLINGTON, N.J., Aug. 13, 2026 GLOBE NEWSWIRE -- Burlington Stores, Inc. NYSE: BURL , a nationally recognized...Here is how Burlington Stores BURL and Casey's General Stores CASY have performed compared to their sector so far this...Burlington Stores BURL is at a 52-week high, but can investors hope for more gains in the future?

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 311.26
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 311.26
  • Analyst targets imply +12.9% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Analyst targets imply +12.9% versus the current price
  • Revenue growth of +14.1%
  • P/E ratio of 34.6

Key Metrics & Analysis

Financial Health

Revenue Growth14.10%
Profit Margin5.24%
P/E Ratio34.6
ROE39.14%
ROA6.09%
Debt/Equity319.73
P/B Ratio11.4
Op. Cash Flow$1.3B
Free Cash Flow$210.8M

Technical Analysis

TrendBullish
RSI38.8
Support$331.79
Resistance$378.33
MA 20$359.48
MA 50$341.98
MA 200$311.26
MACDBearish
VolumeIncreasing
Fear & Greed Index93.14

Valuation

Target Price$380.56
Upside/Downside12.94%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.02
Volatility31.88%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.